The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
13030 results
Assessment
This report presents the findings and recommendations of the first assessment conducted in Lithuania. This involved a desk review of relevant documents, followed by a five-day country visit that took place between 15 September and 19 September 2025.
ECDC Public Health Emergency Preparedness Assessment for Lithuania, 2024
English (3.75 MB - PDF)
Update
ECDC has published its annual activity report for 2025, bringing scientific expertise and risk management together with strengthened cooperation and outreach.
ECDC corporate
This report summarises the work carried out by ECDC in 2025.
Consolidated Annual Activity Report 2025
English (16.39 MB - PDF)
Information on surveillance, data sharing, and reporting protocols on avian influenza.
Operational support
This updated edition of the laboratory handbook introduces several important revisions reflecting the evolving epidemiology of pertussis and advances in diagnostic and molecular surveillance technologies.
Laboratory diagnosis and molecular surveillance of Bordetella pertussis
English (5.38 MB - PDF)
Public health guidance
This table and accompanying algorithm provide guidance for EU/EEA public health authorities, decision-makers, and healthcare professionals on risk categorisation and management of individuals potentially exposed to Ebola disease. The guidance applies to contacts of confirmed or probable cases following travel to, residence in, or work in Ebola outbreak-affected areas, as well as to occupational exposures.
Assessment
In this report, we present estimates of the probability of importation of Ebola disease caused by Bundibugyo virus (BDBV), into EU/EEA countries for the period 11–25 June 2026 under different assumptions of travel volumes from the areas where most cases were reported from.
Estimation of the importation risk of Bundibugyo virus into the EU/EEA in June 2026
English (515.05 KB - PDF)
On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern.
Guidance, training materials and operational resources for public health authorities, healthcare professionals and transport operators.
Communication materials and resources for the public, healthcare professionals, airlines and airport staff.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 June, and includes updates on measles, Nipah virus infection, Chikungunya virus disease, Hantavirus, Ebola, and West Nile virus.
Communicable disease threats report, 6 - 12 June 2026, Week 24.pdf
English (2.36 MB - PDF)
This list below shows the current accommodation sites in EU/EEA countries with which clusters of Legionnaires’ disease have been identified but where the European Legionnaires’ disease Surveillance Network (ELDSNet) is unable to assess the risk of Legionella infection, or where ELDSNet believe there may be increased risk to travellers.
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
Surveillance and monitoring
Weekly update with the latest reports on West Nile virus cases in Europe.
Infographic
Healthcare professionals play a critical role in the early identification and safe management of suspected Ebola disease cases. Imported cases in Europe are expected to be very rare.
Public health guidance
The overall risk of Bundibugyo virus transmission through substances of human origin (SoHO) in the European Union/European Economic Area (EU/EEA) is currently assessed as very low.
Risk of Bundibugyo virus transmission through substances of human origin in the European Union/European Economic Area (EU/EEA)
English (250.38 KB - PDF)
External link
On 4 June 2026, the European Union Reference Laboratory for Public Health on AMR (EURL-PH-AMR) published the ‘Summary report on EARS-Net EQA 2025’. It describes the results of the 2025 external quality assessment (EQA) exercise for antimicrobial susceptibility testing (AST) by clinical laboratories that participate in the European Antimicrobial Resistance Surveillance Network (EARS-Net).
Infographic
Healthcare professionals play a critical role in the early identification and safe management of suspected Ebola disease cases. Imported cases in Europe are expected to be very rare.
Operational support
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
EpiPulse Cases - Reporting Protocol for integrated respiratory virus surveillance, version 1.2
English (1.64 MB - PDF)
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Map
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Map
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Map
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2026, and includes updates on SARS-CoV-2 variant classification, Ebola, Middle East respiratory syndrome (MERS), mpox, West Nile virus, Salmonella, Dermatophilus congolensis and malaria.
Communicable disease threats report, 30 May - 5 June 2026, Week 23
English (5.26 MB - PDF)